Physician

Malia Bree Downing, MD

According to 2025 Medicare claims, Malia Downing, MD (NPI: 1013445071) practices dermatology in the Anniston-Oxford, AL market, with the plurality of this provider's patient population coming from Calhoun, AL. This provider's primary affiliated billing organization is SSD, LLC (NPI: 1134700131; TIN: 861744710) and primary practice location at 36203-1951.

Downing's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 199 traditional Medicare patients, billed 1,311 HCPCS/CPT codes, and received $183,433 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 917 prescription claims across 375 beneficiaries totaling $10,682 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). Open Payments data shows 70 records totaling $2,073. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $788 to $10,682. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$93K$186K2021 Medicare payment: $111,645 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $185,973 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $178,377 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $183,433 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20215302,961$111,645
20226444,231$185,973
20233531,550$178,377
20241991,311$183,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$199K$397K2018 Drug cost: $788 (USD; Tot_Drug_Cst)2019 Drug cost: $1,574 (USD; Tot_Drug_Cst)2020 Drug cost: $1,354 (USD; Tot_Drug_Cst)2021 Drug cost: $58,634 (USD; Tot_Drug_Cst)2022 Drug cost: $397,246 (USD; Tot_Drug_Cst)2023 Drug cost: $148,274 (USD; Tot_Drug_Cst)2024 Drug cost: $10,682 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$788
20191332$1,574
2020N/R17$1,354
2021206358$58,634
2022373878$397,246
2023373850$148,274
2024375917$10,682

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks80113$425
17313Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks4250$422
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4054$63
17000Destruction of precancer skin growth, 1 growth6377$30
17003Destruction of precancer skin growth, 2-14 growths45214$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gentamicin SulfateGentamicin Sulfate661,381$2,349
Doxycycline HyclateDoxycycline Hyclate3501,792$2,164
MupirocinMupirocin2725,209$2,105
Clobetasol PropionateClobetasol Propionate32830$1,026
KetoconazoleKetoconazole34980$552

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$2,073ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Malia Bree Downing, MD?

Tedicare shows public-source Medicare data for Malia Bree Downing, MD (NPI 1013445071), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Malia Bree Downing, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Malia Bree Downing, MD?

Malia Bree Downing, MD is linked to SSD, LLC (billing NPI 1134700131) in the available physician profile data.

Does Malia Bree Downing, MD have Open Payments data?

Malia Bree Downing, MD has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.